ArticleDiagnostic cytopathology2026
Improving Detection Efficiency of FNAC and BRAF V600E Mutation in Thyroid Nodules Using Pipette Mixing: A Retrospective Study.
Article in Diagnostic cytopathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPapillary thyroid carcinoma (PTC) is the most common endocrine malignancy, with a significant subset of cases harboring the BRAF V600E mutation. Fine-needle aspiration cytology (FNAC) combined with BRAF V600E mutation detection is a standard diagnostic approach for thyroid nodules. However, sample heterogeneity often leads to inconsistent results between cytological and molecular analyses. This study aimed to evaluate whether pipette mixing of FNAC samples improves the detection efficiency and diagnostic accuracy of the BRAF V600E mutation in thyroid nodules.
methodsA retrospective analysis was conducted on 360 FNAC samples, divided into pipette-mixed group (n = 180) and a non-mixed group (n = 180). Samples were classified using The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC), and BRAF V600E mutation status was assessed using ARMS-PCR. Diagnostic performance between preoperative FNAC and BRAF V600E mutation detection was compared between the two groups.
resultsPipette mixing substantially reduced the proportion of samples with undetectable BRAF V600E mutations, thereby increasing the yield of interpretable results (p < 0.05). In the non-mixed group, 12 samples fell below the detection limit, compared to only 2 in the mixed group. The proportion of TBSRTC Category III samples was lower in the mixed group (12/180) than in the non-mixed group (38/180, p < 0.05). Pipette-mixed FNAC combined with BRAF V600E testing improved preoperative diagnostic efficiency, particularly for thyroid nodules with indeterminate or non-diagnostic cytology.
conclusionsPipette mixing of FNAC samples improves the detection efficiency of BRAF V600E mutation and enhances diagnostic accuracy for thyroid nodules, especially in challenging cases. This simple technique may optimize preoperative diagnosis and guide clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.